Article · 19 Jun 2025
EditorialPublished 2014
Patent Execution Strategies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Patents are considered to be enticements for innovation and thereby expected to benefit humanity by making available to the society. Pharmaceutical patents cover products that take a very long time to develop and the patent life is actually closer to 11 or 12 years since federal law requires a company to test its product for safety and efficacy and secure regulatory approval before marketing. Developing countries experience shows that such incentives focus on the market demand rather than the need of the society. This is more obvious in the health related innovation. Therefore, a strong IP protections safeguard should be held against counterfeit, illegitimate and fake pharmaceutical products.
Subjects
Business & ManagementAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Opinion · 3 Jul 2023
Patent Infringement: Understanding the Nature, Impact, and Enforcement
Mini review · 26 Sep 2022
Patent Infringement: Turning into a matter of concern
Research article · 30 Jan 2010
Market behavior of patent infringement litigations
Research article · 2013
Research on Pharmaceuticals Patents in Times of Big Data: A Contribution of the Web 2.0 for Medicinal Chemistry
More from this journal
The newest in Intellectual Property Rights: Open Access.
Article · 18 Jun 2026
Patent Law and the Protection of Innovation in the Changing Intellectual Property Landscape
Article · 18 Jun 2026
Trademark Infringement and the Protection of Brand Identity in Intellectual Property Law
Article · 18 Jun 2026
The Debate on Copyright Abolition Within Intellectual Property Law
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIntellectual Property Rights: Open Access
- SubjectBusiness & Management
- BylineArticles whose byline prints “Md. Faiyazuddin”

